Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1968 Dec;31(6):543–551. doi: 10.1136/jnnp.31.6.543

Thalidomide neuropathy: a clinical electrophysiological, and histological follow-up study.

P M Fullerton, D J O'Sullivan
PMCID: PMC496421  PMID: 4303800

Full text

PDF
543

Images in this article

546Image
on p.546

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. CAVANAGH J. B. PERIPHERAL NERVE CHANGES IN ORTHO-CRESYL PHOSPHATE POISONING IN THE CAT. J Pathol Bacteriol. 1964 Apr;87:365–383. doi: 10.1002/path.1700870217. [DOI] [PubMed] [Google Scholar]
  2. CRAGG B. G., THOMAS P. K. THE CONDUCTION VELOCITY OF REGENERATED PERIPHERAL NERVE FIBRES. J Physiol. 1964 May;171:164–175. doi: 10.1113/jphysiol.1964.sp007369. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. DAWSON G. D. The relative excitability and conduction velocity of sensory and motor nerve fibres in man. J Physiol. 1956 Feb 28;131(2):436–451. doi: 10.1113/jphysiol.1956.sp005473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. FABRO S., SCHUMACHER H., SMITH R. L., WILLIAMS R. T. TERATOGENIC ACTIVITY OF THALIDOMIDE AND RELATED COMPOUNDS. Life Sci. 1964 Sep;3:987–992. doi: 10.1016/0024-3205(64)90109-2. [DOI] [PubMed] [Google Scholar]
  5. FULLERTON P. M., KREMER M. Neuropathy after intake of thalidomide (distaval). Br Med J. 1961 Sep 30;2(5256):855–858. doi: 10.1136/bmj.2.5256.855. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Fabro S., Schumacher H., Smith R. L., Stagg R. B., Williams R. T. The metabolism of thalidomide: some biological effects of thalidomide and its metabolites. Br J Pharmacol Chemother. 1965 Oct;25(2):352–362. doi: 10.1111/j.1476-5381.1965.tb02055.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Fabro S., Smith R. L., Williams R. T. Thalidomide as a possible biological acylating agent. Nature. 1965 Dec 18;208(5016):1208–1209. doi: 10.1038/2081208a0. [DOI] [PubMed] [Google Scholar]
  8. Fullerton P. M., Barnes J. M. Peripheral neuropathy in rats produced by acrylamide. Br J Ind Med. 1966 Jul;23(3):210–221. doi: 10.1136/oem.23.3.210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. GILLIATT R. W., SEARS T. A. Sensory nerve action potentials in patients with peripheral nerve lesions. J Neurol Neurosurg Psychiatry. 1958 May;21(2):109–118. doi: 10.1136/jnnp.21.2.109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Gutmann E., Sanders F. K. Recovery of fibre numbers and diameters in the regeneration of peripheral nerves. J Physiol. 1943 Mar 25;101(4):489–518. doi: 10.1113/jphysiol.1943.sp004002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. HIRSCHBERG E., OSNOS M., BRYANT S., ULTMANN J. E. THALIDOMIDE: EFFECTS ON ENZYMES OF GLUTAMIC ACID METABOLISM IN MICE. Science. 1964 Mar 20;143(3612):1343–1344. [PubMed] [Google Scholar]
  12. Hafström T. Polyneuropathy after neurosedyn (thalidomide) and its prognosis. Acta Neurol Scand. 1967;43(Suppl):Suppl32–Suppl3241. [PubMed] [Google Scholar]
  13. Lascelles R. G., Thomas P. K. Changes due to age in internodal length in the sural nerve in man. J Neurol Neurosurg Psychiatry. 1966 Feb;29(1):40–44. doi: 10.1136/jnnp.29.1.40. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. MCCOLL J. D., GLOBUS M., ROBINSON S. AN ATTEMPTED REVERSAL OF THALIDOMIDE EMBRYOPATHY IN THE RAT BY GLUTAMINE. Can J Physiol Pharmacol. 1965 Jan;43:69–73. doi: 10.1139/y65-008. [DOI] [PubMed] [Google Scholar]
  15. O'Sullivan D. J., Swallow M. The fibre size and content of the radial and sural nerves. J Neurol Neurosurg Psychiatry. 1968 Oct;31(5):464–470. doi: 10.1136/jnnp.31.5.464. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. RAFFAUF H. J. [Does thalidomide (contergan) cause injurious effects?]. Dtsch Med Wochenschr. 1961 May 12;86:935–938. doi: 10.1055/s-0028-1112880. [DOI] [PubMed] [Google Scholar]
  19. SCHEID W., WIECK H. H., STAMMLER A., KLADETZKY A., GIBBELS E. [Polyneuritic syndrome after prolonged thalidomide medication]. Dtsch Med Wochenschr. 1961 May 12;86:938–940. doi: 10.1055/s-0028-1112881. [DOI] [PubMed] [Google Scholar]
  20. SIMPSON J. A. THALIDOMIDE NEUROPATHY. Br Med J. 1963 Dec 14;2(5371):1527–1527. doi: 10.1136/bmj.2.5371.1527. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Schumacher H., Smith R. L., Williams R. T. The metabolism of thalidomide: the spontaneous hydrolysis of thalidomide in solution. Br J Pharmacol Chemother. 1965 Oct;25(2):324–337. doi: 10.1111/j.1476-5381.1965.tb02053.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Staemmler M., Lagler F. Tierexperimentelle Untersuchungen zur Frage Thalidomid und Nervenschädigung. Arzneimittelforschung. 1965 May;15(5):504–508. [PubMed] [Google Scholar]
  23. Swallow M. Fibre size and content of the anterior tibial nerve of the foot. J Neurol Neurosurg Psychiatry. 1966 Jun;29(3):205–213. doi: 10.1136/jnnp.29.3.205. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. THOMAS P. K. Growth changes in the myelin sheath of peripheral nerve fibres in fishes. Proc R Soc Lond B Biol Sci. 1955 Mar 15;143(912):380–391. doi: 10.1098/rspb.1955.0018. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES